Compare Boston Scientific Corporation (BSX) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Eli Lilly And Co — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Eli Lilly And Co trades at $1,213.06 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 15.4× Boston Scientific Corporation's market cap, and Eli Lilly And Co pays a 0.56% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | LLY | |
|---|---|---|
Market Cap | $71.46B | $1.10T |
Sector | Health | Health |
52-Week High | $108.14 | $1.24K |
52-Week Low | $42.63 | $639.43 |
Enterprise Value | $83.55B | $1.14T |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
